bipolar - Nursing Case Study

Pathophysiology

• Neurotransmitter dysregulation: Imbalances in neurotransmitters, primarily norepinephrine, serotonin, and dopamine, lead to mood instability. These chemical fluctuations drive the manic and depressive episodes characteristic of bipolar disorder, impacting mood, energy, and cognition.

• Neuroanatomical alterations: Structural and functional changes in brain regions like the prefrontal cortex and limbic system contribute to impaired emotional regulation. These alterations affect decision-making and impulse control, exacerbating mood swings.

• Key complication: Mood episode cycling can lead to severe functional impairment, increased risk of suicide, and comorbid conditions like substance use disorders, necessitating comprehensive management strategies.

Patient Profile

Demographics:

45-year-old female, corporate lawyer

History:

• Key past medical history: Bipolar I disorder diagnosed at age 30, history of rapid cycling, previous hospitalization for manic episodes, hypertension, type 2 diabetes

• Current medications: Lithium, Olanzapine, Metformin, Lisinopril, Atorvastatin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe depressive episode with suicidal ideation

• Key symptoms: Insomnia, significant weight loss, persistent sadness, irritability, difficulty concentrating, auditory hallucinations

• Vital signs: Blood pressure 180/110 mmHg, heart rate 110 bpm, respiratory rate 22 breaths per minute, temperature 99.8°F, blood glucose 250 mg/dL

Section 1

New Diagnostic Results:

Following the initial assessment, a comprehensive panel of diagnostic tests was conducted to further evaluate the patient's current condition and to guide treatment adjustments. The results highlighted significant lithium toxicity with serum lithium levels measuring at 2.0 mEq/L, well above the therapeutic range of 0.6-1.2 mEq/L. This finding is consistent with her symptoms of confusion, auditory hallucinations, and irritability. Additionally, the patient's renal function tests revealed a concerning elevation in creatinine levels at 2.1 mg/dL, indicating possible lithium-induced nephrotoxicity. Her liver function tests showed elevated AST and ALT levels, suggesting hepatic strain, potentially exacerbated by her medication regimen and metabolic syndrome.

The patient's psychiatric evaluation confirmed severe depressive symptoms with a Beck Depression Inventory score of 36, indicating severe depression. The presence of auditory hallucinations points to a possible psychotic feature overlaying the depressive episode. An EEG was also performed due to recent episodes of confusion and revealed intermittent slowing, but no epileptiform activity, suggesting diffuse cerebral dysfunction rather than seizure activity.

These diagnostic findings necessitate immediate intervention to address the lithium toxicity and possible organ dysfunction. The interdisciplinary team must collaborate to adjust her medication regimen, considering both her psychiatric and medical comorbidities. The challenge lies in balancing the stabilization of her mood disorder while mitigating the risks associated with polypharmacy and her current physiological stressors. These results set the stage for a critical reevaluation of her treatment plan and prompt a closer monitoring of her physiological parameters to prevent further deterioration.

Section 2

Change in Patient Status:

In the hours following the identification of lithium toxicity, the patient's condition began to show signs of further deterioration. Her vital signs revealed significant hypotension with a blood pressure reading of 88/56 mmHg, accompanied by tachycardia with a heart rate of 112 bpm. These hemodynamic changes raised concerns about potential lithium-induced cardiovascular compromise. Neurologically, she exhibited increased disorientation and lethargy, scoring a 9 on the Glasgow Coma Scale, reflecting a decline in her level of consciousness. Her respiratory rate was noted to be slightly elevated at 22 breaths per minute, and she exhibited mild respiratory alkalosis on arterial blood gas analysis, with a pH of 7.47 and a reduced PaCO2 of 32 mmHg.

The nursing team, in collaboration with the attending physicians, initiated an immediate lithium clearance protocol, prioritizing aggressive hydration with intravenous normal saline to promote renal excretion of lithium. Concurrently, nephrology was consulted to evaluate the need for possible hemodialysis, considering her elevated creatinine and compromised renal function, which posed a risk for further accumulation of lithium. The psychiatric team also convened to discuss a temporary cessation of lithium therapy, weighing the risk of mood destabilization against the immediate need to manage toxicity.

As the team worked to stabilize her condition, additional complications emerged. The patient developed mild jaundice, and her total bilirubin levels increased to 3.2 mg/dL, suggesting worsening hepatic function, likely multifactorial in origin but exacerbated by her current medication load. A closer examination of her medication regimen and dietary intake was underway to identify and eliminate potential hepatotoxic agents. The complexity of her case necessitated vigilant monitoring and reevaluation of her treatment plan, highlighting the delicate balance of managing her psychiatric needs while addressing the emergent medical complications.

Section 3

New Complications:

As the team continued to address the multifaceted challenges presented by the patient's condition, a new complication arose. The patient began exhibiting signs of acute peripheral edema, particularly notable in the lower extremities, accompanied by a sudden weight gain of 3 kilograms over 24 hours. This development raised concerns about potential fluid overload, possibly exacerbated by the aggressive hydration regimen initiated to enhance lithium clearance. A bedside ultrasound was conducted, revealing mild pleural effusions bilaterally and raising suspicions of early congestive heart failure, likely precipitated by both the fluid management strategy and the underlying cardiovascular stress from lithium toxicity.

Concurrently, laboratory results indicated a rising blood urea nitrogen (BUN) level of 48 mg/dL and creatinine level of 2.1 mg/dL, suggesting worsening renal function despite ongoing interventions. Her electrolyte panel showed hyponatremia with a sodium level of 130 mmol/L, which, coupled with her neurological status, raised the possibility of syndrome of inappropriate antidiuretic hormone secretion (SIADH) as a contributing factor. These findings necessitated a reevaluation of her fluid management plan, with the nephrology team recommending a more conservative approach and the consideration of diuretics to alleviate the fluid overload while preventing further renal compromise.

The interprofessional team faced the challenge of managing these new complexities while ensuring the patient's psychiatric stability. The psychiatric team, recognizing the risks of abrupt mood destabilization, initiated a low-dose atypical antipsychotic to provide some mood stabilization without exacerbating her medical condition. This complex interplay of medical and psychiatric management required the team to continually assess and adjust the treatment plan, emphasizing the need for advanced clinical judgment and interdisciplinary collaboration to navigate the evolving clinical landscape.

Section 4

As the clinical team continued to navigate the complexities of the patient's condition, a change in patient status became evident. Over the next 48 hours, the patient developed a persistent cough and increased respiratory rate, registering at 24 breaths per minute, alongside a low-grade fever of 38.2°C (100.8°F). Auscultation of the lungs revealed decreased breath sounds at the bases with crackles, suggesting worsening pulmonary involvement. Pulse oximetry showed a saturation drop to 90% on room air, prompting the initiation of supplemental oxygen therapy.

The patient's neurological status also showed subtle changes; she became increasingly lethargic and disoriented, unable to recognize family members during their visit. Her Glasgow Coma Scale (GCS) score decreased from 15 to 13, with notable deficits in verbal responses. These developments demanded urgent reevaluation of her therapeutic regimen, particularly examining the balance between managing her psychiatric symptoms and her deteriorating physical health.

In response to the new developments, the care team decided to prioritize stabilization of the patient's respiratory and renal functions. A chest X-ray confirmed the presence of bilateral pleural effusions, and the decision was made to initiate a low-dose loop diuretic to manage the fluid overload, carefully monitoring her electrolyte balance to mitigate the risk of further hyponatremia. The nephrology team adjusted her fluid intake to prevent further renal strain, while the psychiatric team opted to maintain the antipsychotic regimen at the lowest effective dose to mitigate mood destabilization. The patient's evolving clinical picture underscored the need for continuous monitoring and ongoing interdisciplinary collaboration to tailor interventions according to her rapidly changing status.

Section 5

The patient's response to the interventions over the next 24 hours revealed both encouraging and concerning developments. Initially, her respiratory status showed mild improvement; with supplemental oxygen, her saturation levels increased to 94%, and her respiratory rate decreased to 20 breaths per minute. However, auscultation still revealed persistent crackles and decreased breath sounds, indicating ongoing pulmonary challenges. Despite the initiation of the loop diuretic, her fluid status required closer examination. Repeat chest X-rays showed minimal reduction in the pleural effusions, prompting the medical team to consider alternative strategies, including thoracentesis, to relieve her respiratory distress.

Concurrently, new laboratory results provided additional insights into her physiological status. Blood tests indicated a worsening renal function with a serum creatinine level rising to 2.1 mg/dL, and an estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73 m², raising concerns about acute kidney injury potentially exacerbated by the diuretics. Electrolyte panels showed mild hyponatremia with sodium levels at 130 mmol/L, necessitating a reevaluation of her fluid management strategy to prevent further complications. Furthermore, a complete blood count revealed leukocytosis with a white blood cell count of 15,000/mm³, suggesting a possible underlying infection contributing to her fever and systemic instability.

These findings necessitated a shift in the clinical approach, emphasizing the need for aggressive management of her potential infection and careful balancing of her renal and respiratory support. The interdisciplinary team convened to discuss the initiation of broad-spectrum antibiotics while awaiting culture results, and to refine her diuretic regimen to prevent exacerbating her renal impairment. The complexity of managing her bipolar disorder alongside these evolving medical issues highlighted the critical need for dynamic clinical reasoning and vigilant monitoring, as the team prepared for potential further complications.